Unlock instant, AI-driven research and patent intelligence for your innovation.

A nucleic acid aptamer for detecting human bladder transitional cell carcinoma cells and its application in the preparation of detection preparations

A nucleic acid aptamer, transitional cell technology, applied in measurement devices, biochemical equipment and methods, instruments, etc., can solve the problem of atypical or degenerative cells with a small number of cancer cells, cannot rule out low-grade urothelial cancer, Low sensitivity of bladder cancer, etc., to achieve the effect of short cycle, easy labeling and good reproducibility

Active Publication Date: 2018-05-04
HUNAN UNIV
View PDF5 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Sensitivity is closely related to the malignant grade of cancer cells. Bladder cancer with low grade has low sensitivity. On the one hand, it is because the tumor cells are well differentiated, and their characteristics are similar to normal cells, so it is difficult to identify them. Tight, not enough cancer cells shed into the urine to be detected, so a negative urine cytology does not rule out the presence of low-grade urothelial carcinoma
In addition, factors such as low number of cancer cells in urine specimens, atypical or degenerated cells, urinary tract infection, stones, bladder perfusion therapy, and technical differences of examiners will affect the results of urine cytology.
Although most urinary bladder cancer markers show high sensitivity, their specificity is generally lower than that of urine cytology. So far, there is still no ideal marker that can replace cystoscopy and urine cytology. Make sufficient judgments on the diagnosis, treatment, postoperative follow-up and prognosis of bladder cancer

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • A nucleic acid aptamer for detecting human bladder transitional cell carcinoma cells and its application in the preparation of detection preparations
  • A nucleic acid aptamer for detecting human bladder transitional cell carcinoma cells and its application in the preparation of detection preparations
  • A nucleic acid aptamer for detecting human bladder transitional cell carcinoma cells and its application in the preparation of detection preparations

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0027] Example 1: High-throughput detection and data analysis

[0028] After repeated verification, it was determined that the library with the strongest binding ability screened for another cancer cell line had a strong specific binding to the T24 cell line. We sent the library to the Sangon Sequencing Department, using Illumina Miseq or Hiseq2000 The platform was sequenced and generated more than 150,000 raw data. We selected the top 100 sequences with the most occurrences by analyzing the original data and combining the number of occurrences of each sequence, and compared the homology of these 100 sequences to classify the sequences with close homology into a family. Finally, select representative sequences from each family and select 10 sequences for further verification based on the sequence of occurrence (see Table 1).

[0029] Table 1

[0030]

Embodiment 2

[0031] Example 2: Determining the sequence with the strongest specific binding ability to the T24 cell line

[0032]First, digest the adherent T24 cells from the culture dish with 0.2% EDTA and 2% EDTA, collect the cells into centrifuge tubes, and centrifuge with washing buffer (PBS, containing 0.45% glucose, 5mM magnesium chloride) Wash several times; secondly, add the 10 sequences and the random library with a final concentration of 250nM to the binding buffer (D-PBS, containing 0.45% glucose, 5mM magnesium chloride, 100mg / L tRNA, 1g / L BSA) soaked In T24 cells; then place it on a shaker at 4°C and incubate for 40min; after incubation, centrifuge and wash twice with washing buffer (PBS, containing 0.45% glucose, 5mM magnesium chloride), and perform fluorescence detection by flow cytometry (results see figure 2 , only a few representative sequences are shown in the figure). The test results showed that D7 had the strongest binding ability with T24 cells.

Embodiment 3

[0033] Example 3: D7 specifically recognizes human bladder transitional cell carcinoma cells

[0034] This experiment has similarities with certain processing steps in cell-selection technology (CELL-SELEX). First, digest adherent T24 and SV-HUC-1 from the culture dish with 0.2% EDTA and 2% EDTA, respectively, collect the cells into centrifuge tubes, and wash with washing buffer (PBS, containing 0.45% Glucose, 5mM magnesium chloride) centrifugation and washing several times; Add equal amount of binding buffer (D-PBS, containing 0.45% glucose, 5mM magnesium chloride, 100mg / L tRNA, 1g / L BSA to T24 and SV-HUC-1 respectively ), and put into D7 and random library with a final concentration of 250nM; then placed on a shaker at 4°C and incubated for 40min; Fluorescent detection by flow cytometry (results in image 3 ). The results showed that D7 had high affinity and specifically combined with T24 cells, but not with normal SV-HUC-1 cells.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
Sensitivityaaaaaaaaaa
Login to View More

Abstract

The invention discloses a nucleic acid aptamer for detecting human bladder transitional cell carcinoma cells (T24) and application of the nucleic acid aptamer to preparation of detection preparations. Compared with the prior art, the nucleic acid aptamer and application thereof have the advantages that the found nucleic acid aptamer with no immunogenicity has higher affinity and specificity than associated protein antibodies, can be synthesized chemically in vitro, is small in molecular weight, capable of modifying and substituting for different parts of nucleic acid aptamers, stable in sequence, convenient to store and mark and the like; the nucleic acid aptamer is simpler and rapider to operate when being used for human bladder transitional cell carcinoma cell detection, and is lower in synthesis cost than antibody preparation cost, short in period and good in reproducibility.

Description

technical field [0001] The invention relates to a nucleic acid aptamer and its application, in particular to a nucleic acid aptamer which can be used for detection of human bladder transitional cell carcinoma cells and clinical sample tissues and an application method for preparing a detection reagent. Background technique [0002] Bladder cancer is one of the most common clinical tumors in urology in my country, and it is a disease that directly threatens the survival of patients. Worldwide, the incidence of bladder cancer ranks ninth in malignant tumors, sixth in men and tenth in women. In Europe and the United States, the incidence of bladder cancer ranks fourth among male malignancies, behind prostate cancer, lung cancer, and colon cancer, and ranks tenth among female malignancies. In 2002, the age-standardized incidence rate of bladder cancer in the world was 10.1 / 100,000 for men and 2.5 / 100,000 for women, and the age-standardized mortality rate was 4 / 100,000 for men a...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C12N15/115G01N33/574
CPCC12N15/115C12N2310/16C12N2310/30C12N2310/33C12N2310/3517G01N33/57407
Inventor 叶茂谭蔚泓龙禹乾段敏兰
Owner HUNAN UNIV